Published in Curr Opin Pediatr on August 01, 2012
Bullous mastocytosis mimicking congenital epidermolysis bullosa. Case Rep Dermatol (2014) 0.75
Mastocytosis among elderly patients: A multicenter retrospective French study on 53 patients. Medicine (Baltimore) (2016) 0.75
Childhood mastocytosis: results of a single center. Turk Pediatri Ars (2015) 0.75
One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes. Am J Pathol (2003) 1.72
Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol (2011) 1.63
Mastocytosis: pathology, genetics, and current options for therapy. Leuk Lymphoma (2005) 1.61
Recent advances in the understanding of mastocytosis: the role of KIT mutations. Br J Haematol (2007) 1.47
Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. J Allergy Clin Immunol (2010) 1.46
Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. Leuk Res (2003) 1.39
Early changes in hippocampal Eph receptors precede the onset of memory decline in mouse models of Alzheimer's disease. J Alzheimers Dis (2009) 1.29
Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes. J Allergy Clin Immunol (2010) 1.22
Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J Allergy Clin Immunol (2009) 1.15
Dermoscopic features of skin lesions in patients with mastocytosis. Arch Dermatol (2011) 1.14
Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Abeta levels. Neurobiol Dis (2008) 1.13
Flow cytometry criteria for systemic mastocytosis: bone marrow mast cell counts do not always count. Am J Clin Pathol (2013) 1.10
Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations. Am J Clin Dermatol (2011) 1.09
Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease. Int Arch Allergy Immunol (2002) 1.07
Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis. J Allergy Clin Immunol (2012) 1.07
Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5. J Immunol (2008) 1.05
Evaluation of the WHO criteria for the classification of patients with mastocytosis. Mod Pathol (2011) 1.01
Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis. J Allergy Clin Immunol (2008) 1.00
Complete response after imatinib mesylate therapy in a patient with well-differentiated systemic mastocytosis. J Clin Oncol (2012) 0.95
Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis. J Allergy Clin Immunol (2013) 0.88
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis. Histopathology (2013) 0.87
Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome. PLoS One (2013) 0.86
Metastatic cutaneous plasmacytoma presenting as a perianal giant mass. Dermatol Online J (2008) 0.84
The European Competence Network on Mastocytosis (ECNM). Wien Klin Wochenschr (2004) 0.81
Adherence to immunotherapy in times of financial crisis. Ann Allergy Asthma Immunol (2013) 0.81
Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders. Methods Cell Biol (2011) 0.81
Short-term omalizumab treatment in an adolescent with cutaneous mastocytosis. Ann Allergy Asthma Immunol (2013) 0.80
Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis. Immunotherapy (2011) 0.80
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives. Wien Klin Wochenschr (2012) 0.80
Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment. Curr Allergy Asthma Rep (2006) 0.79
The effects of thyroid hormones on circulating markers of cell-mediated immune response, as studied in patients with differentiated thyroid carcinoma before and during thyroxine withdrawal. Eur J Endocrinol (2005) 0.79
Management of Anesthesia in Adult and Pediatric Mastocytosis: A Study of the Spanish Network on Mastocytosis (REMA) Based on 726 Anesthetic Procedures. Int Arch Allergy Immunol (2015) 0.79
Flow cytometric analysis of intestinal intraepithelial lymphocytes in the diagnosis of refractory celiac sprue. Eur J Gastroenterol Hepatol (2008) 0.78
Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion. Mod Pathol (2012) 0.78
Calcium-pH crosstalks in the human mast cell line HMC-1: intracellular alkalinization activates calcium extrusion through the plasma membrane Ca2+-ATPase. J Cell Biochem (2006) 0.77
STI571 (Glivec) affects histamine release and intracellular pH after alkalinisation in HMC-1560, 816. J Cell Biochem (2008) 0.77
Influence of the tyrosine kinase inhibitors STI571 (Glivec), lavendustin A and genistein on human mast cell line (HMC-1(560)) activation. J Cell Biochem (2008) 0.76
Indolent systemic mastocytosis without skin involvement vs. isolated bone marrow mastocytosis. Haematologica (2011) 0.75
Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis. Br J Haematol (2003) 0.75
Anemia, leukocytosis, abdominal pain, flushing, and bone and skin lesions. Cleve Clin J Med (2012) 0.75
[Pool palms]. Dermatol Online J (2009) 0.75
Study of Cognitive Function in Children Treated with Propranolol for Infantile Hemangioma. Pediatr Dermatol (2017) 0.75
Congenital ulcer of the buttock. Pediatr Dermatol (2013) 0.75
Aplasia Cutis Congenita Associated with Fetus Papyraceus. Pediatr Dermatol (2015) 0.75
Mastocytosis, Kounis syndrome and medical emergencies. Intern Emerg Med (2014) 0.75
Segmental prurigo pigmentosa. Pediatr Dermatol (2014) 0.75
Extensive Intracranial Arteriovenous Malformation in a Child with Aplasia Cutis Congenita. Pediatr Dermatol (2015) 0.75